Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Journal of Infectious Diseases & Travel Medicine Research Article 20 min read

The Role of Medical Microbiologists in Advancing the Frontiers of Travel Medicine

Enitan SS*, Okuneye AO, Iduh UM, Akele RY, Edafetanure-Ibeh OM, Awe OJ, Fagboyegun WA and Adetosoye AO
* Corresponding author
ISSN: 2640-2653  10.23880/jidtm-16000181  Received: December 26, 2023  Published: February 28, 2024
 — views
 48 references
 2 tables
PDF
Keywords
Travel Medicine Medical Microbiologists Microbial Threats Antibiotic Stewardship Global Health
Abstract

The essential role of medical microbiologists in the field of travel medicine becomes apparent amidst the escalating challenges faced by our world. This article highlights their indispensable contributions to safeguarding global health during travel. Medical microbiologists play a pivotal part in defending against infectious threats encountered during travel, identifying and characterizing novel pathogens, developing rapid diagnostic tools, and spearheading outbreak investigations for early detection and containment. Their active involvement in vaccine development and surveillance is critical for ensuring the safety of travelers, and they address vaccine hesitancy through educational initiatives and advocacy. Moreover, they combat the growing issue of antimicrobial resistance, influencing travel health guidelines and promoting prudent antimicrobial use to minimize resistance risks. Collaboration is paramount in tackling global health threats, and medical microbiologists facilitate the exchange of information, reinforcing global surveillance networks to respond effectively to emerging infections. Their role in training the next generation of experts ensures a sustainable and knowledgeable workforce in travel medicine. As we navigate the continually evolving landscape of travel, the expertise of medical microbiologists becomes increasingly vital. Their dedication to advancing travel medicine through research, education, and collaborative efforts ensures that travel remains a positive force, promoting exploration while mitigating health risks. Recognizing and supporting their endeavors contribute to building a safer and healthier future for travelers and communities worldwide.

Introduction

The act of traveling has been an intrinsic part of human existence, serving various purposes such as exploration, trade, cultural exchange, and education throughout history. In our contemporary interconnected global society, there has been a significant increase in international travel, bringing both enrichment and notable challenges to public health [1]. The urgent need for a proactive approach to travel medicine is underscored by the emergence of infectious diseases, the threat of antimicrobial resistance, and the ongoing risk of pandemics [2]. In this modern era where travel is an integral aspect of life, the field of travel medicine, crucial for ensuring the health and well-being of travelers, sees medical microbiologists, particularly those specializing in infectious diseases, as key figures [3, 4, 5].

Travel medicine, as a multidisciplinary domain, encompasses various fields to address the unique health risks associated with traversing diverse regions and cultures. Drawing on epidemiology, clinical medicine, public health, tropical medicine, and preventive medicine, it offers a comprehensive approach to managing traveler health [6].

The primary goals of travel medicine include pre-travel assessments, immunizations, guidance on travel-related risks, and post-travel evaluations. Achieving these objectives requires collaborative efforts among healthcare providers, epidemiologists, immunologists, and notably, medical microbiologists. The pivotal role of medical microbiologists in unraveling the complexities of infectious diseases linked to global travel deserves closer scrutiny [7, 8].

The interconnected nature of global travel has transformed the world, providing unprecedented opportunities for exploration, trade, education, and cultural exchange. However, this interconnectedness also poses substantial challenges to public health, including the emergence of infectious diseases, the rise of antimicrobial resistance, and the constant threat of pandemics, emphasizing the need for a comprehensive and proactive approach to travel medicine [2, 9, 10].

As a field, travel medicine encompasses diverse disciplines aimed at addressing the unique health risks encountered during travel. Amidst increasingly complex health challenges, medical microbiologists play a pivotal role in deciphering the intricacies of infectious diseases, significantly contributing to the advancement of travel medicine [11].

In a world where global travel’s interconnectivity has generated both opportunities and challenges, medical microbiologists work diligently behind the scenes to safeguard traveler health [12]. Their expertise in infectious diseases shapes the practice of travel medicine, ensuring that individuals can explore the world safely and confidently [13]. Medical microbiologists serve as indispensable guardians of traveler health, specializing in infectious diseases. Their proficiency in identifying, diagnosing, treating, and preventing infections caused by microorganisms is crucial in travel medicine. Their multifaceted role involves monitoring global disease trends, providing insights into disease prevalence, enabling risk assessments, and offering pre- travel health advice. They play a pivotal role in developing and evaluating vaccines for travel-related diseases, ensuring travelers receive appropriate protection [14].

In instances of illness during or after travel, medical microbiologists diagnose causative agents through various lab techniques, preventing the spread of diseases. They combat antimicrobial resistance by monitoring resistant bacteria and recommending effective antibiotic treatments, thus safeguarding travelers. During travel-related disease outbreaks, they collaborate with health organizations and authorities to investigate sources, track spread, and implement vital control measures for containment. Additionally, medical microbiologists contribute to research on travel-related diseases, formulate guidelines, and educate healthcare providers and travelers on disease risks, prevention, and responsible antibiotic use [15, 16].

This review paper explores the indispensable contributions of medical microbiologists in advancing the frontiers of travel medicine. It delves into the foundation of travel medicine, the expertise medical microbiologists bring, their role in disease detection, prevention, and research, as well as their collaborative efforts towards global health. Furthermore, the paper addresses the challenges faced by the field and outlines the future directions that medical microbiologists will shape.

Travel and Microbial Threats

Travel exposes individuals to a multitude of microbial threats, setting the stage for a dynamic interplay between human immunity and a variety of microorganisms that can lead to various health issues. Crossing borders introduces travelers to new environments, climates, and local customs, each presenting a distinct microbiological landscape [17]. Key transmission zones for pathogens include airports, airplanes, and crowded tourist spots. Contagious infections such as the flu, colds, and gastrointestinal illnesses can rapidly spread through close contact and shared surfaces in these settings. However, the spectrum of microbial threats extends beyond these common adversaries. Numerous regions pose a significant risk of waterborne pathogens, as contaminated water sources may contain bacteria, viruses, and parasites, leading to severe diarrheal diseases. Furthermore, local food choices, street vendors, and restaurant hygiene practices may introduce unfamiliar pathogens. In certain destinations, insect-borne diseases transmitted by mosquitoes and ticks, such as malaria, dengue fever, Zika virus, and Lyme disease, pose significant risks, necessitating appropriate preventive measures [6, 18]. The diversity of encountered pathogens during travel is influenced by factors such as destination, duration of stay, activities, local hygiene practices, and individual susceptibility. Notable pathogens include:

Viral Pathogens

Travel exposes individuals to viral diseases such as influenza, hepatitis, and, in high-risk regions, emerging viruses (e.g., Ebola, Zika and COVID-19). Vaccination is crucial for preventing some of these infections [19, 20].

Bacterial Pathogens

These include species causing gastrointestinal infections (e.g, Salmonella spp., Escherichia coli), respiratory infections (e.g., Streptococcus pneumoniae, Mycobacterium tuberculosis), and skin infections (e.g., Staphylococcus aureus).

Parasitic Pathogens

Protozoa (e.g., Giardia lambia, Entamoeba histolytica) and helminths (e.g., Schistosoma spp., Ascaris lumbricodes) are encountered in regions with inadequate sanitation and water hygiene.

Fungal Pathogens

Fungal infections like dermatophytosis (e.g., ringworm) and candidiasis can occur, especially in humid environments or due to compromised skin integrity. Understanding the diverse range of infectious agents and associated risks is crucial for ensuring a safe and healthy journey for travelers. Table 1 provides an overview of some prevalent travel- related infections, their associated pathogens, modes of transmission, and geographic distribution of these diseases [21, 22, 23].

Pathogen(s)TransmissionGeographic Distribution
MalariaPlasmodium speciesMosquito-borneTropical and subtropical
Traveler’s DiarrheaVarious bacterial pathogensFecal-oralWorldwide, especially in developing regions
Typhoid FeverSalmonella typhiFecal-oralEndemic in many countries
Dengue FeverDengue virusMosquito-borneTropical and subtropical regions
Hepatitis AHepatitis A virusFecal-oralWorldwide
ChikungunyaChikungunya virusMosquito-borneAsia, Africa, Americas

Table 1: Common Travel-Related Infections and Pathogens.

High-Risk Regions and Unique Microbiological Challenges

Tropical Regions

Characterized by elevated humidity, tropical areas create ideal conditions for disease vectors like mosquitoes. Mosquitoes are responsible for transmitting diseases such as malaria, dengue, and Zika. Inadequate sanitation in these regions contributes to the prevalence of waterborne diseases.

Crowded Urban Centers

Highly populated cities in developing nations face challenges related to sanitation, waste management, and overcrowding. Consequently, the risk of infectious diseases, including cholera, typhoid, and respiratory infections, escalates in urban environments.

Remote Areas

Journeys to less-developed, remote regions expose individuals to unique pathogens due to limited healthcare infrastructure and challenges in accessing medical assistance.

Animal Contact

Regions with common human-animal interactions raise concerns about zoonotic diseases such as rabies and specific influenza strains.

Antimicrobial Resistance

High-risk regions often have limited access to appropriate antibiotics, leading to the emergence and spread of drug-resistant pathogens. Travelers can navigate these challenges by adhering to good hygiene practices, receiving essential vaccinations, taking preventive medications, and seeking local health advice. Adapting to the distinctive microbiological challenges of each region is crucial for ensuring a safe and healthy travel experience.

The Expertise of Medical Microbiologists

Medical microbiology, a scientific discipline, focuses on studying microorganisms and their impact on human health. Microbiologists identify, classify, and study these organisms systematically. Their specialized knowledge in identification, characterization, and treatment of infectious agents enables them to guide treatment decisions.

The Role of Medical Microbiologists in Travel Medicine

Pre and post travel health advisories: Guidance from medical microbiologists is crucial for customized pre- and post-travel consultations beyond routine vaccinations. Recommendations are tailored based on factors like destination, planned activities, and underlying health conditions [14, 24].

Detection of infectious diseases: Medical microbiologists play a pivotal role in identifying and characterizing causative agents in travelers returning with infections. Rapid and precise diagnostic tests aid in early disease detection, crucial for preventing cross-border infection spread [6, 25].

Global disease surveillance: Microbiologists contribute to global disease surveillance by analyzing data to track geographic distribution and transmission patterns of pathogens. Collaboration with international organizations and public health agencies forms a robust defense against pandemics [3, 26, 27].

Disease prevention: Medical microbiologists contribute significantly to vaccine development, crucial for preventing infectious diseases prevalent in destination regions [28, 29, 30].

Empirical treatment guidance: Medical microbiologists guide empirical treatment by initiating treatment before definitive microbiological results are available. Their expertise helps optimize patient care, prevent infectious disease spread, and address antimicrobial resistance [18, 31].

Antibiotic Stewardship

In the domain of travel medicine, medical microbiologists advocate for antibiotic stewardship principles, as emphasized by Bokhary, et al. [18]. Their focus centers on promoting the prudent use of antibiotics, emphasizing the necessity of administering these medications only when essential, prescribing the correct drug at the appropriate dosage, and ensuring the completion of the entire treatment regimen. This conscientious approach aims to mitigate the emergence and spread of antibiotic-resistant bacteria. Additionally, medical microbiologists actively monitor the prevalence of resistant strains and variations in different geographical regions, collaborating with public health agencies to identify trends in antimicrobial resistance (AMR). By understanding local resistance patterns, these professionals assist clinicians in selecting optimal treatment strategies, thereby reducing the risk of treatment failure [11, 27].

Innovative Diagnostic Technologies in Travel Medicine

Medical microbiologists play a key role in developing cutting-edge diagnostic technologies essential for disease diagnosis and monitoring, especially in scenarios where access to healthcare facilities is limited for travelers [34]. They actively contribute to the creation of rapid, point- of-care tests designed for resource-limited environments, emphasizing low-cost, robust, and globally deployable tools. Simultaneously, they lead advancements in molecular diagnostic techniques such as PCR and next-generation sequencing, enabling early and accurate identification of pathogens, particularly crucial in cases of emerging or rare diseases [5, 6, 35].

Facilitating Global Health Collaboration

Medical microbiologists collaborate extensively with clinicians, epidemiologists, public health agencies, and researchers from diverse fields to formulate comprehensive strategies addressing travel-related health challenges [5]. Within this collaborative framework, their specialized knowledge of microorganisms and infectious diseases plays a pivotal role. By synergizing with clinicians, epidemiologists, and public health agencies, medical microbiologists contribute to the development of robust diagnostic and monitoring approaches that consider both clinical and epidemiological factors. This multidisciplinary approach ensures a thorough examination of every aspect of a health challenge, encompassing not only immediate clinical consequences but also potential spread, evolution, and the impact of travel [36].

Contribution to International Travel Health Guidelines

Medical microbiologists play a crucial role in shaping International Travel Health Guidelines by leveraging their expertise in microbiology, infectious diseases, and epidemiology. These guidelines, essential for the health and safety of travelers, benefit from the profound understanding medical microbiologists bring to microbiological intricacies, infectious disease dynamics, and epidemiological principles. In an era marked by increased global mobility and diverse health risks encountered during travel, their wisdom becomes invaluable, ensuring consistent and evidence-based recommendations for travelers worldwide [5, 32, 37].

Contribution to Global Health Security

The contributions of medical microbiologists significantly enhance global health security by preventing the worldwide dissemination of infectious diseases and advocating for health equity among travelers. Serving as essential guardians of public health on a global scale, they leverage their expertise in microorganisms to devise and implement effective strategies for containing outbreaks. Their surveillance, diagnosis, and containment efforts are fundamental in protecting populations worldwide, addressing both immediate clinical consequences and the broader epidemiological landscape. Additionally, they champion health equity for travelers, ensuring access to essential health services irrespective of origin or destination [38, 39].

Public Health Communication

In the realm of infectious diseases, medical microbiologists play a vital role in public education, elucidating the modes of transmission, emphasizing hygiene, and promoting vaccination. Their efforts empower individuals to take proactive measures to safeguard themselves and their communities. By communicating research findings and recommendations clearly and accurately to the public, healthcare providers, and policymakers, medical microbiologists ensure that necessary actions are taken to prevent pathogen transmission and preserve public health. This dedication is evident in their precise and transparent communication, essential in countering the spread of pathogens [40, 41, 42, 43].

Infection Control

Medical microbiologists play a pivotal role in infection control within travel medicine, collaborating with healthcare institutions to establish protocols that minimize healthcare- associated infections and uphold rigorous hygiene standards. Their commitment to public health drives their active engagement in designing, implementing, and continuously improving infection control measures, particularly crucial in the dynamic field of travel medicine. In a world where global movement is prevalent, their expertise remains indispensable [44, 45].

Advancements in Microbiology Driving Progress in Travel Medicine

Remarkable progress has been made in the field of travel medicine, greatly enhancing the well-being and safety of travelers, thanks to substantial contributions from microbiological research [46].

Vector-Borne Diseases

Microbiological research has been instrumental in understanding and combating diseases transmitted by vectors. Investigation into pathogens carried by insects, particularly mosquitoes, has facilitated the development of innovative prevention strategies and measures for vector control. Notable outcomes include the creation of insecticide- treated bed nets and more effective mosquito repellents. These advancements significantly reduce the vulnerability to diseases like malaria, dengue, and Zika, especially in regions where these diseases are prevalent [21, 47].

Emerging Infectious Diseases

Microbiological research is crucial for the early detection of emerging pathogens. Progress in genomic sequencing, epidemiological research, and surveillance has empowered researchers to promptly identify and characterize novel infectious agents. Swift identification enables authorities to implement control measures, curbing the international spread of diseases. Examples include the rapid response to outbreaks such as Ebola and COVID-19, where microbiological research played a pivotal role in understanding the pathogens and developing diagnostic tests [48].

Vaccination Strategies

Microbiological research has led to the development of innovative vaccines against travel-related diseases, including Japanese Encephalitis and Yellow Fever. Expertise in unraveling the molecular and genetic aspects of pathogens has proven indispensable in vaccine development. These vaccines provide travelers with protection against potentially life-threatening diseases, allowing them to explore high-risk regions with reduced health concerns [30].

Antimicrobial Resistance Surveillance

The growing threat of antimicrobial resistance poses a significant risk to travelers, as common infections may become challenging to treat. Microbiological research is crucial in monitoring and combating drug-resistant pathogens among travelers. Research aids in understanding resistance mechanisms and guides the formulation of novel treatments and policies for judicious antibiotic use. This ensures that travelers can receive effective treatment when needed [9, 11].

Diagnostics and Point-of-Care Tests

Microbiological research has resulted in the development of rapid and precise diagnostic tools for travel- related diseases. Point-of-care tests and advanced laboratory techniques facilitate swift identification of pathogens, even in resource-limited settings. These tools are crucial for on-site testing and prompt treatment decisions, enabling healthcare professionals to offer timely care to travelers who may fall ill during their journeys [34].

Challenges and Prospects in Travel Medicine

Travel medicine, dedicated to the health and safety of individuals planning travel to diverse regions or countries, faces significant challenges and offers numerous prospects. Medical microbiologists play a pivotal role in addressing these challenges and shaping the future of travel medicine (Table 2).

ChallengesProspectsRole of Medical Microbiologists
1Outbreaks of new and re-emerging infections (e.g., COVID-19, Zika, Ebola) present a constant threat to travelers.Advances in diagnostic techniques, surveillance systems, and global collaboration can help identify and contain outbreaks quickly.Play a pivotal role in advancing and executing intricate diagnostic assessments, keeping an eye on the emergence of new pathogens, and furnishing real-time information to authorities concerned with public health.
2The rise of drug-resistant microbes complicates treatment options, especially in resource-limited settings.Research and innovation in antimicrobial drugs and alternative treatments can combat antibiotic-resistant infections.Engage in comprehending the intricacies of antibiotic resistance mechanisms, identifying novel drug targets, and steering the judicious use of antibiotics to curtail resistance.
3Travelers may lack up-to-date vaccinations for diseases prevalent in the destination, increasing the risk of outbreaks.Expanding vaccination access and education can prevent outbreaks and protect both travelers and local populations.Participate actively in vaccine research, effectiveness inquiries, and public outreach efforts highlighting the significance of vaccinations for travelers.
4Mosquitoes, ticks, and other vectors can transmit diseases like malaria, dengue, and Lyme disease.Enhanced vector control measures, protective clothing, and repellents can reduce the transmission of vector-borne diseases.Explore the behaviors of disease vectors, contribute to managing resistance to insecticides, and formulate innovative approaches for controlling vector populations.
5Contaminated food and water can lead to travel related diarrhea.Improved hygiene and awareness of food and water safety can reduce the incidence of travel-related diarrhea.Contribute to the monitoring of pathogens in food and water, devise swift detection methodologies, and advocate for hygiene practices.
6Travelers from different socio-economic backgrounds may face unequal access to healthcare and travel health resources.Efforts to reduce health disparities in travel medicine can lead to better outcomes for all travelers, regardless of their background.Champion the cause of fair access to resources for travel health, offer culturally attuned advice, and collaborate with various entities to ensure impartial dispensation of healthcare services.
7Collecting and sharing travel health data while ensuring privacy and security is a challenge in the digital age.Improved data encryption, secure sharing protocols, and ethical data practices can protect traveler privacy while enabling better disease tracking and management.Take part in shaping secure data management systems, establishing ethical guidelines for data utilization, and playing a role in safeguarding the confidentiality of sensitive health data.
8Changing environmental conditions (e.g., climate change) can impact travel health, leading to new disease vectors and health risks.Strategies to address environmental health risks, along with adaptation measures, can mitigate the impact of changing conditions on travel health.Participate in evaluating the health ramifications of evolving environments, scrutinizing how disease vectors respond to shifts in climate, and advising on measures to mitigate health risks stemming from environmental changes.

Table 2: Challenges and Prospects in Travel medicine.

The Future of Travel Medicine and the Evolving Role of Medical Microbiologists

In the ever-evolving landscape of travel medicine, a promising future is emerging, characterized by the seamless integration of data-driven approaches, cutting-edge diagnostics, and collaborative efforts across various fields. At the forefront of this evolution, medical microbiologists play a pivotal role, propelling the field into a new era of comprehensive healthcare customized for travelers. Advanced diagnostics are instrumental in shaping the course of travel medicine, with significant advancements in biotechnology, including next-generation sequencing, point- of-care testing, and artificial intelligence-driven diagnostics, fundamentally transforming our ability to identify and manage infectious diseases.

The evolving role of medical microbiologists is evident in their adept use of these state-of-the-art technologies to precisely identify pathogens, detect antimicrobial resistance, and tailor treatment strategies accurately. This shift towards precision medicine is crucial in travel medicine, ensuring that each traveler receives personalized and effective care based on their unique risks and needs. Armed with profound knowledge of pathogens and diagnostic methodologies, medical microbiologists are strategically positioned to lead the way in harnessing the power of advanced diagnostics. Through their expertise, they can streamline the diagnosis process, initiate prompt treatment, and mitigate the potential spread of infectious agents. This not only protects the health of individual travelers but also contributes to the global control of communicable diseases.

However, the journey towards the future of travel medicine is not a solitary pursuit; it demands a holistic, multidisciplinary approach. Medical microbiologists must collaborate closely with epidemiologists, public health experts, immunologists, and travel medicine specialists. This interdisciplinary collaboration fosters a comprehensive understanding of the interconnected factors influencing travel health, addressing the complexities of emerging pathogens, vaccine strategies, and preventive measures.

Conclusion

In conclusion, in the dynamic realm of travel medicine, where health and exploration intersect, medical microbiologists serve as unwavering guardians, ensuring that the excitement of discovery does not compromise health. They are indispensable in the field of travel medicine, offering expertise that spans disease detection, prevention, research, and global health collaboration. Through driving innovation and sharing knowledge, medical microbiologists uphold the health and safety of travelers in an increasingly interconnected world. Their expertise, research, and dedication to understanding the microbial world empower us all to embark on journeys with confidence, expanding the frontiers of exploration while safeguarding the health of humanity.

Disclosure Statement

No potential conflict of interest was reported by the author(s)

Funding

This compilation is a review article written by its authors and required no substantial funding to be stated.

Contributions of Authors

ESS and OAO: Conceptualization and writing of the original draft, critical revision, and final approval of the submitted version. IUM, ARY and EOM: Writing of the original draft, critical revision of the submitted version. AOJ, FWA and AAO: Writing of the original draft, critical revision, and final approval of the submitted version.

References

  1. Chen LH, Leder K, Barbre K, Schlagenhauf P, Libman, et al. (2018) Business travel-associated illness: a GeoSentinel analysis. Journal of Travel Medicine 25(1).
  2. Sandrock C, Aziz SR (2020) Travel/Tropical medicine and pandemic considerations for the global surgeon. Oral and Maxillofacial Surgery Clinics of North America 32(3): 407-425.
  3. Schwartz KL, Morris SK (2018) Travel and the spread of Drug-Resistant bacteria. Current Infectious Disease Reports 20(29).
  4. Hoenigl M, Gangneux J, Segal E, Alanio A, Chakrabarti A (2018) Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together. Mycoses 61(11): 885-894.
  5. Hu F, Wen J, Zheng D, Wang W (2023) Travel medicine in hospitality: an interdisciplinary perspective. International Journal of Contemporary Hospitality Management 35(9): 3134-3153.
  6. Ellwanger JH, Veiga GD, Kaminski DL, Villegas JVM, Freitas AWQ (2021) Control and prevention of infectious diseases from a One Health perspective. Genetics and Molecular Biology 44(1): e20200256.
  7. Balaban V, Warnock E, Dhara VR, Louis JLA, Sotir MJ, et al. (2014) Health risks, travel preparation, and illness among public health professionals during international travel. Travel Medicine and Infectious Disease 12(4): 349-354.
  8. Riddle MS, Connor BA, Beeching NJ, DuPont HL, Hamer DH, et al. (2017) Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report. Journal of Travel Medicine 24(1): S57-S74.
  9. Katz R, Fernandez J, McNabb SJN (2010) Disease surveillance, capacity building and implementation of the International Health Regulations. BMC Public Health 10(1).
  10. Khatib A, Carvalho A, Primavesi R, To K, Poirier V (2020) Navigating the risks of flying during COVID-19: a review for safe air travel. Journal of Travel Medicine 27(8).
  11. Frost I, Boeckel TPV, Pires J, Craig J, Laxminarayan R (2019) Global geographic trends in antimicrobial resistance: the role of international travel. Journal of Travel Medicine 26(8).
  12. Suk JE, Cangh TV, Beaute J, Bartels C, Tsolova S, et al. (2014) The interconnected and cross-border nature of risks posed by infectious diseases. Global Health Action 7(1): 25287.
  13. Hamer DH, Rizwan A, Freedman DO, Kozarsky PE, Libman M (2020) GeoSentinel: past, present and future. Journal of Travel Medicine 27(8).
  14. Hatz C, Chen LH (2019) Pretravel consultation. Elsevier eBooks, pp: 25-30.
  15. Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO (2006) The Practice of travel Medicine: Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 43(12) 1499-1539.
  16. Sharun K, Tiwari R, Natesan S, Yatoo MI, Malik YS, et al. (2020) International travel during the COVID-19 pandemic: implications and risks associated with ‘travel bubbles. Journal of Travel Medicine 27(8).
  17. Baker RF, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, et al. (2021). Infectious disease in an era of global change. Nature Reviews Microbiology 20(4): 193-205.
  18. Bokhary H, Pangesti KNA, Rashid H, Ghany ME, Hill- Cawthorne GA (2021). Travel-Related Antimicrobial Resistance: A Systematic review. Tropical Medicine and Infectious Disease 6(1): 11.
  19. Misra V, Agrawal R, Kumar H, Kar A, Kini U, et al. (2020) Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists. Indian Journal of Pathology & Microbiology 63(3): 350.
  20. Wilder‐Smith A (2021) COVID-19 in comparison with other emerging viral diseases: risk of geographic spread via travel. Tropical Diseases, Travel Medicine and Vaccines 7(1).
  21. Kularatne SM, Dalugama C (2022) Dengue infection: Global importance, immunopathology and management. Clinical Medicine 22(1): 9-13.
  22. Mourad O, Makhani L, Chen LH (2022) Chikungunya: an emerging public health concern. Current Infectious Disease Reports 24(12): 217-228.
  23. Damme VP, Pinto RM, Feng Z, Cui F, Gentile A, et al.(2023) Hepatitis A virus infection. Nature Reviews Disease Primers 9(1).
  24. Tulchinsky TH, Varavikova EA (2014) A history of public health. Elsevier eBooks, pp: 1-42.
  25. Lai S, Farnham A, Ruktanonchai NW, Tatem AJ (2019) Measuring mobility, disease connectivity and individual risk: a review of using mobile phone data and mHealth for travel medicine. Journal of Travel Medicine 26(3).
  26. Murray J, Cohen AL (2017) Infectious disease surveillance. Elsevier eBooks, pp: 222-229.
  27. Salam A, Al-Amin M, Salam MT, Pawar JS, Akhter N, et al. (2023) Antimicrobial resistance: a growing serious threat for global public health. Healthcare 11(13): 1946.
  28. Steffen R, Rickenbach M, Wilhelm U, Helminger A, Şchar M (1987) Health problems after travel to developing countries. The Journal of Infectious Diseases 156(1): 84- 91.
  29. Steffen R, Behrens RH, Hill DR, Greenaway C, Leder K (2015) Vaccine‐Preventable travel Health Risks: What is the Evidence-What are the gaps? Journal of Travel Medicine 22(1): 1-12.
  30. Pavli A, Maltezou HC (2022) Travel vaccines throughout history. Travel Medicine and Infectious Disease 46: 102278.
  31. Greenway A, Butterton JR (2018) New frontiers in antimicrobial leadership: an interview with Joan Butterton. Future Microbiology 13(15).
  32. Bauer I (2022) COVID-19: how can travel medicine benefit from tourism’s focus on people during a pandemic? Tropical Diseases. Travel Medicine and Vaccines 8(1).
  33. Leshem E, Schwartz E (2019b) Fever in returned travelers. Elsevier eBooks, pp: 495-504.
  34. Muldrew KL (2009) Molecular diagnostics of infectious diseases. Current Opinion in Pediatrics 21(1): 102-111.
  35. Canton R (2005b) Role of the microbiology laboratory in infectious disease surveillance, alert and response. Clinical Microbiology and Infection 11(1): 3-8.
  36. Du M, Yuan J, Jing W, Liu M, Liu J (2022) The effect of international travel arrivals on the new HIV infections in 15-49 years aged group among 109 countries or territories from 2000 to 2018. Frontiers in Public Health 10.
  37. Ostroff SM, Kozarsky PE (1998) Emerging Infectious Diseases And Travel Medicine. Infectious Disease Clinics of North America 12(1): 231-241.
  38. Oladele RO, Osaigbovo II, Ayanlowo O, Otu A, Hoenigl M, et al. (2018) The role of medical mycology societies in combating invasive fungal infections in low- and middle- income countries: A Nigerian model. Mycoses 62(1): 16- 21.
  39. Pappas MG (1988) Recent applications of the Dot-ELISA in immunoparasitology. Veterinary Parasitology 29(2- 3): 105-129.
  40. Isenring E, Fehr J, Gultekin N, Schlagenhauf P (2018) Infectious disease profiles of Syrian and Eritrean migrants presenting in Europe: A systematic review. Travel Medicine and Infectious Disease 25: 65-76.
  41. Torresi J, Leder K (2009) Defining infections in international travellers through the GeoSentinel surveillance network. Nature Reviews Microbiology 7(12): 895-901.
  42. Torresi J, McGuinness SL, Leder K, OBrien DP, Ruff T, et al. (2019) Principles of Pre-travel Healthcare. Manual of travel medicine pp: 1-17.
  43. Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS (2017) 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clinical Infectious Diseases 65(12): e45-e80.
  44. Wilson M, Weld L, Boggild AK, Keystone JS, Kain KC, et al. (2007) Fever in Returned Travelers: Results from the GeoSentinel Surveillance Network. Clinical Infectious Diseases 44(12): 1560-1568.
  45. Smith R, Chanda R, Tangcharoensathien V (2009) Trade in health-related services. The Lancet 373(9663): 593- 601.
  46. Sulaiman LH (2022) Travel medicine: Travelling to space and the reality on the ground. International e-Journal of Science Medicine & Education 16(1): 1-2.
  47. Samuel L, Hansen GL, Kraft CS, Pritt BS (2021) The need for dedicated microbiology leadership in the clinical microbiology laboratory. Journal of Clinical Microbiology 59(8).
  48. Morales RAJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P (2020) Going global-Travel and the 2019 novel coronavirus. Travel Medicine and Infectious Disease 33: 101578.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{enitan2024,
  title   = {The Role of Medical Microbiologists in Advancing the Frontiers of Travel Medicine},
  author  = {Enitan SS, Okuneye AO, Iduh UM, Akele RY, Edafetanure-Ibeh OM, Awe OJ, Fagboyegun WA and Adetosoye AO},
  journal = {Journal of Infectious Diseases & Travel Medicine},
  year    = {2024},
  volume  = {8},
  number  = {1},
  doi     = {10.23880/jidtm-16000181}
}
Enitan SS, Okuneye AO, Iduh UM, Akele RY, Edafetanure-Ibeh OM, Awe OJ, Fagboyegun WA and Adetosoye AO (2024). The Role of Medical Microbiologists in Advancing the Frontiers of Travel Medicine. Journal of Infectious Diseases & Travel Medicine, 8(1). https://doi.org/10.23880/jidtm-16000181
TY  - JOUR
TI  - The Role of Medical Microbiologists in Advancing the Frontiers of Travel Medicine
AU  - Enitan SS, Okuneye AO, Iduh UM, Akele RY, Edafetanure-Ibeh OM, Awe OJ, Fagboyegun WA and Adetosoye AO
JO  - Journal of Infectious Diseases & Travel Medicine
PY  - 2024
VL  - 8
IS  - 1
DO  - 10.23880/jidtm-16000181
ER  -